U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pathogen: clinical or host-associated sample from Escherichia coli

Identifiers
BioSample: SAMN16304317; Sample name: R13-CV1-pSow-02
Organism
Escherichia coli
cellular organisms; Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Escherichia
Package
Pathogen: clinical or host-associated; version 1.0
Attributes
collected byAgriculture and Agri-Food Canada
collection date2017-05-24
geographic locationCanada: Quebec
isolation sourcefeces
latitude and longitudemissing
hostSus scrofa domesticus
host diseasemissing
serotypeO23:H30
strainR13-CV1-pSow-02
BioProject
PRJNA662792 Escherichia coli
Retrieve all samples from this project

Submission
Agriculture and Agri-Food Canada, Jean-Simon Brouard; 2020-09-30
Antibiogram
AntibioticResistance phenotypeMeasurement signMeasurementMeasurement unitsLaboratory typing methodLaboratory typing platformVendorLaboratory typing method version or reagentTesting standard
ampicillinresistant>32mg/LMICSensititerCLSI
azithromycinsusceptible==4mg/LMICSensititerCLSI
cefoxitinsusceptible==4mg/LMICSensititerCLSI
ceftriaxonesusceptible<0.25mg/LMICSensititerCLSI
chloramphenicolresistant==32mg/LMICSensititerCLSI
ciprofloxacinsusceptible<0.015mg/LMICSensititerCLSI
gentamicinsusceptible==1mg/LMICSensititerCLSI
meropenemsusceptible<0.06mg/LMICSensititerCLSI
nalidixic acidsusceptible==2mg/LMICSensititerCLSI
streptomycinresistant==32mg/LMICSensititerCLSI
sulfisoxazoleresistant>256mg/LMICSensititerCLSI
tetracyclineresistant>32mg/LMICSensititerCLSI
amoxicillin-clavulanic acidsusceptible==8/1mg/LMICSensititerCLSI
piperacillin-tazobactamsusceptible<4/1mg/LMICSensititerCLSI
cefazolinsusceptible<8mg/LMICSensititerCLSI
cephalothinintermediate==16mg/LMICSensititerCLSI
cefotaximesusceptible<0.25mg/LMICSensititerCLSI
cefpodoximesusceptible<0.25mg/LMICSensititerCLSI
ceftazidimesusceptible<0.25mg/LMICSensititerCLSI
cefotaxime-clavulanic acidnot defined<0.12/1mg/LMICSensititerCLSI
ceftazidime-clavulanic acidnot defined==0.25/1mg/LMICSensititerCLSI
cefepimesusceptible<1mg/LMICSensititerCLSI
imipenemsusceptible<0.5mg/LMICSensititerCLSI
trimethoprim-sulfamethoxazoleresistant>4/1mg/LMICSensititerCLSI
Accession:
SAMN16304317
ID:
16304317

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center